twenty-five adults who harbored malignant gliomas received 72 courses of intraarterial 1,3-bis ( 2-chloroethyl ) -1-nitrosourea ( bcnu ) ( 100 mg/m2 ) and 67 courses of systemic vincristine ( 1.0 mg/m2 ) and procarbazine ( 100 mg/m2 ) as induction therapy ( bvp ) followed by 106 courses of systemic 1- ( 2-chloroethyl ) -3- ( 4-methylcyclohexyl ) -1-nitrosourea ( methyl-ccnu ) ( 130 mg/m2 ) , vincristine , and procarbazine as maintenance therapy ( mvp ) .
C0007257
bcnu
C0279258
bvp